Experimental Drugs Boost Elderly Immune Systems, Raising Hopes For Anti-Aging Effects
(By Rob Stein for NPR) Scientists on the hunt for anti-aging drugs say they’ve made an advance with tantalizing potential:
Read More
Part D/Prescription Drugs
Scientists Find New Tricks For Old Drugs
(By Richard Harris for NPR) Most drugs have side effects, but sometimes they’re actually good news. Researchers are now exploring
Read MoreOpioid stigma is keeping many cancer patients from getting the pain control they need
(By Sara Ray and Kathleen Hoffman for STAT) History is repeating itself. Twenty years ago, a pain management crisis existed.
Read MorePharmaceutical companies are working on ways to evade copay accumulator
In an effort to coax patients away from expensive drugs, pharmacy benefits managers (PBMs) have introduced a new “copay accumulator”
Read MoreWhat A U.S.-China Trade War Could Mean For The Opioid Epidemic
(By Matthew Garcia for Kaiser Health News) The American struggle to curb opioid addiction could become collateral damage in President
Read MoreAs drug resistance grows, combining antibiotics could turn up new treatments
(By Megan Thielking for STAT) Combining certain antibiotics could help them pack a one-two punch against harmful bacteria, according to a new study
Read MoreMedicare’s money traps
Medicare isn’t free and it may end up costing more than you expect. In fact, the entire Medicare spectrum of
Read MorePfizer hikes price of 100 drugs
(By Alia Paavola for Becker’s Hospital Review) Pfizer, the largest pharmaceutical company in the U.S., increased the price of 100
Read MoreAcceleron blood disease drug hits goal in pivotal clinical trial
(By Adam Feurerstein for STAT) Acceleron Pharma said Thursday that its experimental drug luspatercept significantly reduced the need for blood
Read More340B hospitals, contract pharmacies need more
The Government Accountability Office (GAO) said that HHS’ Health Resources and Services Administration (HRSA) should take new steps to ensure
Read More